FAM
NKTR icon

Fred Alger Management’s Nektar Therapeutics NKTR Stock Holding History

Fred Alger Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Sell
53,172
-848
-2% -$48.3K 0.02% 253
2025
Q4 		$2.28M Sell
54,020
-37,787
-41% -$2.11M 0.01% 304
2025
Q3 		$5.22M Buy
91,807
+39,096
+74% +$1.29M 0.02% 236
2025
Q2 		$1.36M Buy
52,711
+18,948
+56% +$213K 0.01% 339
2025
Q1 		$344K Buy
+33,763
New +$441K ﹤0.01% 380
2018
Q2 		– Sell
-67
Closed -$106K – 571
2018
Q1 		$106K Buy
+67
New +$86.3K ﹤0.01% 406
2016
Q3 		– Sell
-2,667
Closed -$569K – 529
2016
Q2 		$569K Sell
2,667
-9,287
-78% -$2.08M ﹤0.01% 372
2016
Q1 		$2.46M Sell
11,954
-8,239
-41% -$1.58M 0.01% 312
2015
Q4 		$5.1M Buy
+20,193
New +$4.15M 0.02% 248

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fred Alger Management's NKTR Position: Q1 2026 in Review

Fred Alger Management reduced its Nektar Therapeutics (NKTR) stake by 1.6% in Q1 2026, selling an estimated $48.3K and leaving 53,172 shares worth $3.83M. The position accounts for 0.02% of the portfolio, ranked #253.

Fred Alger Management first reported a position in NKTR in Q4 2015 and has held it in 9 quarters since. The position peaked at $5.22M in Q3 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Fred Alger Management held 53,172 shares of Nektar Therapeutics worth $3.83M as of Q1 2026.
  • Fred Alger Management sold 848 Nektar Therapeutics shares in Q1 2026, an estimated $48.3K.
  • Nektar Therapeutics made up 0.02% of Fred Alger Management's portfolio in Q1 2026, its #253 holding.
  • Fred Alger Management first reported a position in Nektar Therapeutics in Q4 2015 and has held it in 9 quarters since.
  • Fred Alger Management's Nektar Therapeutics position peaked at $5.22M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.